Molecular Fingerprinting in Cancer Detectio
Recruiting
- Conditions
- C34C61C50C67C00-C14C18C22C25C95J44.1
- Registration Number
- DRKS00019844
- Lead Sponsor
- udwig-Maximilians-Universität München (LMU)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 38000
Inclusion Criteria
Informed consent, = 18 years, healthy subject, or one of the eligible benign or malignant diseases.
Exclusion Criteria
Multiple cancers, any cancer therapy within the last two years, no blood draw possible, participant noncompliance
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective of this study is the accuracy of IMF diagnosis for nine cancer entities, assessed by comparison with all data available to the investigator. A diagnoses is regarded as correct if IMF and clinical routine assessing all available data coincide with regard to the nine tumor entities of interest.
- Secondary Outcome Measures
Name Time Method 1) Capability to reproduce or improve the results of the pilot study<br>2) Capability of IMF to recognize sub-types of tumors and tumor stages<br>3) Capability of IMF to distinguish between patients with any tumors on the one hand and healthy subjects and patients with benign diseases on the other one<br>4) Reliability of IMF with regard to sensibility, specificity, PNT and PPT<br>5) Accuracy of IMF as compared with a conventional FTIR Analyzer<br>6) Gain additional information on IMFs: defining cancer-independent and cancer-dependent parts of IMFs in longitudinal observations